News
Expand filters

Filters

News Type

Services

Locations

Showing 1 - 6 out of 6 results

Patient Story

Walking Strong After Robotic-Assisted Knee Surgery
Last fall, Pam Ludy, 65, took a trip with her sister to North Carolina. But Pam, who has osteoarthritis in both knees, had a hard time walking.

Resources

Get Moving Again: Advanced Nerve Injury Care at Barnes-Jewish Hospital

At Barnes-Jewish Hospital, two WashU Medicine physicians, David Brogan, MD, MSc, and Christopher Dy, MD, MPH, are working on new ways to treat brachial plexus damage, a serious nerve injury. These often occur after major accidents, such as car crashes, and can have a big impact on a person’s ability to use their arm and hand.

News

Barnes-Jewish Hospital Unveils State-of-the-Art Patient Care Tower

ST. LOUIS (September 18, 2025) – Plaza West Tower, the new 16-story patient care tower at Barnes-Jewish Hospital, will welcome patients beginning in October. The tower will provide private rooms for heart and vascular patients, advanced imaging, and the latest in surgical preparation and recovery. Plaza West Tower is designed to enhance the experience for patients and their families under the expert care of WashU Medicine physicians and BJC HealthCare clinical teams.

News

Why Exercise is Key to Bone Health: An Orthopedic Doctor Weighs In
Staying active helps maintain joint flexibility and balance, promotes better posture and strengthens bones.

WashU Medicine, BJC Health System launch Center for Health AI
Washington University School of Medicine and BJC Health System, both located in St. Louis, have launched the joint Center for Health AI to harness the power of cutting-edge artificial intelligence (AI) and fundamentally change the way health care is provided.

Article

Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.